You are here
Pfizer/BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose Vaccine Candidate Against COVID-19 and Influenza
Primary tabs
Pfizer/BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose Vaccine Candidate Against COVID-19 and Influenza
Mon, 2022-12-12 12:59 — mike kraft...
A combined vaccine for influenza and COVID-19 has the potential to simplify immunization practices against two severe respiratory diseases caused by evolving viruses that require vaccine adaptation.
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
Recent Comments